What’s behind Trump’s drug pricing proposal? This insight explores key policy tools, global scenarios, and long-term ...

Professor Graham Cookson responds to Chancellor's Spending Review announcement boosting NHS spend by 3%. Earlier today, UK ...

OECD countries formally use QALYs in pricing and reimbursement decisions. See how HTA practices differ and where policies ...

Antimicrobial resistance (AMR) is a global health crisis, projected to cause up to 10 million deaths annually and impose economic costs exceeding $150 billion by 2050.

In this Insights series, Around the World in HTAs, we shed light on HTA around the world. In this edition, Andrés ...